Demand for safe, effective and science-backed brightening solutions has never been greater. Innovations including polydeoxyribonucleotide (PDRN), exosome-based therapies and proprietary brightening agents such as Lumiskin™ are bringing skin renewal and brightening together.
Why PDRN matters: repair, anti-pigmentation and brightening
PDRN is widely used for its regenerative and wound-healing properties. Research shows it also has anti-pigmentation effects: it reduces melanin content, inhibits tyrosinase activity and stimulates collagen synthesis, contributing to improved firmness, elasticity and barrier integrity (Noh et al., 2016; Khan et al., 2022).
Exosomes: cellular messengers for skincare
Exosomes deliver growth factors and bioactive molecules to skin cells, enhancing repair, promoting collagen production and reducing pigmentation. Clinical studies show topical exosome treatments can improve texture, elasticity, hydration and radiance (Stem Cell Research & Therapy, 2025), making them a strong complement to PDRN.
Lumiskin™: proprietary brightening technology
Lumiskin™ inhibits melanin formation, helping reduce dark spots, hyperpigmentation and uneven tone. In vitro and ex vivo tests confirm its efficacy in reducing tyrosinase activity and melanin synthesis (Croda Beauty, Lumiskin™ technical data). Combined with regenerative actives like PDRN and exosomes, it supports a holistic approach to skin rejuvenation.
Together, regenerative science (PDRN and exosomes) and advanced brightening technology (Lumiskin™) work at the cellular level to repair skin structure, enhance elasticity and reduce pigmentation.
Adapted from the official FLY UP manufacturer article.

